Last reviewed · How we verify
NCT04292210
Human Factors Validation Testing for the Peripal System; a Manual Connection Assist Device for Peritoneal Dialysis Devices
NA trial testing Perisafe in End Stage Renal Failure on Dialysis in 24 participants. Completed in 30 April 2018.
12 March 2018
Quick facts
| Lead sponsor | Peripal AG |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 24 |
| Start date | 19 February 2018 |
| Primary completion | 12 March 2018 |
| Estimated completion | 30 April 2018 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Perisafe
Conditions studied
- End Stage Renal Failure on Dialysis — all drugs for End Stage Renal Failure on Dialysis →
- End Stage Renal Disease on Dialysis — all drugs for End Stage Renal Disease on Dialysis →
- Renal Failure — all drugs for Renal Failure →
- Peritoneal Dialysis — all drugs for Peritoneal Dialysis →
Sponsor
Peripal AG
Who can join
Eligibility, any sex, with End Stage Renal Failure on Dialysis or End Stage Renal Disease on Dialysis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is estimated that there are currently over 3 million patients receiving dialysis treatment worldwide. With effective pre-dialysis counselling, a majority of patients choose the home-based therapy peritoneal dialysis (PD) but only approximately 11% of prevalent dialysis patients use this modality. Connection-assist devices can overcome the challenges posed by decreased manual dexterity and/or visual acuity, and can allow more patients to be treated with home-based therapies. As part of the CE marking authorization, a connection device has been evaluated for safety and ease of use in a usability study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04292210
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for End Stage Renal Failure on Dialysis
Currently open trials in the same condition.
- NCT06056102 — CAR-T Cell Therapy for Desensitization in Kidney Transplantation · Phase 1 · recruiting
- NCT07237633 — Evaluating the Feasibility of a Piezoelectric Smart Sensor as an Aid to Help Clinicians Screen for the Development of Pn · NA · recruiting
- NCT04774770 — HED-Start: Evaluating a Positive Skills Intervention for Patients New on Haemodialysis · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04292210 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peripal AG
- Last refreshed: 3 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04292210.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing